Madrigal Pharmaceuticals, Inc.
MDGLNASDAQHealthcare● Active
$467.28
$-19.70(-4.05%)
Market Cap$10.8B
P/E Ratio—
52W High$615
52W Low$275
Madrigal Pharmaceuticals, Inc.（MDGL）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · MDGL · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.29B) | ($0.47B) | ($0.37B) | ($0.30B) | ($0.24B) |
| Depreciation & Amort. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.10B | $0.08B | $0.05B | $0.03B | $0.03B |
| Change in Working Capital | ($0.01B) | ($0.07B) | ($0.00B) | $0.04B | $0.03B |
| Net Cash from Operations | ($0.19B) | ($0.46B) | ($0.32B) | ($0.22B) | ($0.18B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | ($1.05B) | ($1.13B) | ($0.83B) | ($0.14B) | ($0.39B) |
| Sales of Investments | $1.09B | $0.84B | $0.33B | $0.35B | $0.39B |
| Net Cash from Investing | $0.03B | ($0.27B) | ($0.50B) | $0.21B | ($0.01B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.22B | $0.00B | $0.07B | $0.05B | $0.00B |
| Net Cash from Financing | $0.26B | $0.74B | $0.60B | $0.31B | $0.17B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.19B) | ($0.46B) | ($0.33B) | ($0.23B) | ($0.18B) |
| FCF Margin %(computed) | -19.83% | -253.72% | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Madrigal Pharmaceuticals, Inc.
关于Madrigal Pharmaceuticals, Inc.（MDGL）现金流量表
Madrigal Pharmaceuticals, Inc. 2025财年经营活动现金流($0.19B)，自由现金流($0.19B)（FCF利润率-19.83%），资本支出($0.00B)。
常见问题
MDGL · 4 问Madrigal Pharmaceuticals, Inc. 2025财年自由现金流($0.19B)，同比up58.4%。
MDGL free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10